"MNT-Halan": 124.8k Lawsuits in the Prospectus of the Largest EGP IPO... Does the Price Compensate the Investor for the Risks?

Tracking IPOs for over twenty years has taught me that the biggest number is like a loud Upper-Egyptian slap: it makes a loud sound so everyone turns to look, but the true impact lies elsewhere.

The main shareholder Mounir Nakhla, founder and CEO of "MNT-Halan," is selling shares worth EGP 7.84 billion in the largest EGP-denominated IPO in the history of the Egyptian Exchange, and this is what will make headlines. But anyone flipping through the offering prospectus will find a figure worth reading first: 124.8 thousand lawsuits against defaulting clients, with claims totaling EGP 6.47 billion.

The specific question is: Does the subscription price of EGP 24.5 per share compensate the subscriber for the risks associated with portfolio quality, funding structure, and growth assumptions? Public subscription closes on October 15, with trading expected to begin on October 20. The price is about 5.5% lower than the fair value of EGP 25.92, putting the market capitalization at EGP 39.2 billion.

The average claim per lawsuit is around EGP 52 thousand, representing consumer and microfinance debt—right at the heart of the group's business model. Value is concentrated in "Tasaheel Finance" at EGP 5.79 billion (89.5% of claims), compared to EGP 382.3 million for "Halan Consumer Finance" (5.9%), and EGP 299.4 million for "Mashroey for Trade" (4.6%). Published data does not detail the breakdown of lawsuit counts across the three companies, but it is clear that value is concentrated in the arm with the largest financing portfolio.

Management states that the EGP 6.47 billion represents the total value of disputed financing contracts, not the outstanding client balance, and that it does not exceed 3.5% of the group's total issuances since inception, noting that litigation is a standard collection tool in the sector. According to Commercial International Bank's (CIB) statement, the group served 7.9 million clients from inception through June 2026, making lawsuits equivalent to about 1.6% of them—keeping in mind that a single client may face multiple lawsuits.

These arguments deserve consideration, but they do not answer the question that matters to subscribers. Subscribers need to know the actual outstanding balance involved in these legal cases, the recovery rate management expects to collect, provisions made against them, and the estimated collection timeline. These figures do not appear in the published data reviewed.

Management puts the default rate in portfolios between 4% and 5%, which is a different metric than the 3.5% figure, as the former is calculated on existing portfolios while the latter is based on total issuances since inception. Therefore, it is inappropriate to place these two numbers side by side as if they measure the same thing. The useful comparison would be the balance of active cases against the active portfolio, which is unavailable. For this same reason, comparing EGP 6.47 billion to the IPO size or profits does not reveal potential loss magnitude, as it represents gross contract value rather than losses.

Who Bears the Loss if Portfolios Deteriorate?

"Tasaheel" has eight active securitization issuances worth EGP 31.47 billion as of September 30, while "Halan Consumer Finance" has four issuances totaling EGP 8.07 billion, bringing the total to EGP 39.54 billion. Securitization transfers a debt portfolio to a special purpose entity that issues bonds backed by it, providing the company with liquidity to reinvest in lending. However, transferring the portfolio does not necessarily transfer all risk; if the company retains tranches of the issuance or provides credit enhancements or other obligations, part of the risk remains with it.

This is the key question for shareholders and subscribers: How much risk was actually transferred to securitization bondholders, and how much remains with the subsidiaries and shareholders? The answer grows more critical given the scale of financing, as group assets stood at EGP 44.2 billion against EGP 35.7 billion in liabilities at the end of June, with its subsidiaries borrowing around EGP 31.7 billion. This is a point requiring a clear answer from management before subscription closes.

Main Shareholder Sells EGP 7.84 Billion and Injects Up to 4 Billion

The IPO proceeds represent the price of existing shares, not a single pound of which enters the company's treasury. Afterwards, the same shareholder will subscribe to a closed capital increase of up to EGP 4 billion at the IPO price, retaining approximately 80.47% of the company. If he subscribes in full to the increase, his gross proceeds will exceed his injection by about EGP 3.84 billion, while maintaining control. The new capital entering the company comes from the principal shareholder himself, and subscribers must know how it will be utilized—a detail that published data has not adequately addressed.

Investors are purchasing shares in a holding company reliant on dividend distributions from its subsidiaries, which does not expect to pay dividends for 2026 due to restrictions in certain financing contracts, meaning no immediate cash yield. Employee costs for its ~25,000 workforce accounted for 55% of selling, general, and administrative expenses in H1 2026, making the group's cost control ability a key test of profitability.

A 5.5% Discount on a Valuation Assuming a Surge in Profits

The company has much to boast about: 1.9 million active clients, over 5,000 merchants, and a price below the fair value determined by an independent advisor. However, the discount is narrow relative to the valuation assumptions. The study expects net profit to jump from EGP 3.1 billion in 2027 to EGP 32.2 billion in 2031—more than a tenfold increase in four years, representing a compound annual growth rate (CAGR) of nearly 80%. The projected 2031 profit equals about 82% of the market capitalization at IPO. This does not mean the company is worth one year's profit, but it reveals the sheer scale of the growth bet.

At EGP 39.2 billion, the stock trades at roughly 12.6 times 2027 expected earnings. This multiple cannot be judged without comparing it to listed consumer finance companies, a comparison absent from the published valuation study. If forecasts materialize, the price may seem cheap; if they do not, it will appear high. The first test of this bet lies in H1 2026 performance and its consistency with the study's trajectory.

CIB: A Positive Signal with Conditions

Commercial International Bank (CIB) signed an anchor investor agreement on September 24 to acquire shares worth up to EGP 2 billion, keeping its stake below 5%. Alongside it is a London-based fund committing around $20 million, with management stating that both together cover over one-third of the offering. This is a significant signal from institutional investors, but it comes with conditions, including CIB's right to withdraw if a material event affects the group's financial condition. CIB has a relationship spanning over 15 years with the company; if it holds a lender role or exposure to securitization issues, the implication of its investment differs from an unrelated investor's entry. Meanwhile, retail oversubscription reaching 62% on day one—from a tranche representing just 3% of capital—is insufficient on its own to judge market appetite for the IPO.

What About Government IPOs?

The success of "Halan" is a test of market liquidity and appetite for major listings, but it does not directly measure the readiness of state-owned IPOs, which rely more on governance, revenue stability, and asset quality than on a high-growth narrative. The Minister of Investment had announced in April that "Misr Life Insurance" would list in late June or early July at around EGP 14 billion for a 20% stake, but the deadline passed without an offering, and EGX Chairman Omar Radwan states that Banque du Caire will precede it before year-end. If Halan's share price stabilizes above the subscription price once trading begins, it could boost the morale of the privatization program; if it stumbles, it will add another test to a market attempting to restore investor confidence.

Does the Price Compensate for the Risks?

Based on what has been published so far, a 5.5% discount alone does not seem sufficient to compensate subscribers—it is a narrow margin for a stock whose valuation relies on earnings growing tenfold in four years, lawsuit risks that remain unclear in underlying portfolios, and a securitization structure where risk allocation is not fully transparent. The discount would be far more compelling if four key answers are provided before October 15:

First: The active outstanding balance within lawsuits, provisions set against it, expected recovery rate, and timeline.

Second: The risk limits remaining with subsidiaries and shareholders post-securitization, whether in guarantees, retained tranches, or other liabilities.

Third: The specific uses of proceeds for the EGP 4 billion capital increase.

Fourth: H1 2026 profits compared to the fair value study trajectory.

Anyone who does not find these answers available at closing is buying a growth story with a limited margin of safety, bearing the burden of assessing the risks alone.